CLIENTS

LaMont Aerospace is harnessing microgravity to improve life on earth.  Here are a few investigations LaMont has facilitated utilizing our on-orbit assets:

 

Texas A&M- “ntraterrestrial Fungus Grown in Space (iFunGIS): Determining alterations in                      metabolic processes and products of a subsurface fungus in microgravity
 

•NASA- Exploiting Alterations in Pathogen Pigmentation to Characterize Physiological and                            Cellular Responses to Spaceflight
•ISS National Lab- Effect of Microgravity on Human Thyroid Carcinoma Cells/Phase-I

•ISS National Lab
Effect of Microgravity on Human Thyroid Carcinoma Cells/Phase-II
 

•ISS National LabEffect of Microgravity on Human Thyroid Carcinoma Cells/Phase-III

•ISS National Lab- long-term alterations in primary human macrophages/Phase-I
 

•ISS National Lab- long-term alterations in primary human macrophages/Phase-II

•ISS National Lab- The gravity dependence of pharmacodynamics: the integration of lidocaine into membranes in microgravity

•ISS National Lab/UAA- Tapping Microgravity to Enhance Biofuel Production
 

•UCF- The role of the space environment on vascular endothelial and smooth muscle cell                         processes
 

•NASA/UCLA- The Impact of Microgravity on the Proliferation of Human Neural Stem Cells and derived-Oligodendrocytes
 

•NASA/UCLA- The Impact of Microgravity on the Proliferation of Human Neural Stem Cells and derived-Oligodendrocytes/Phase-II
 

•NiH/Children's Hospital of Philadelphia- Lung Host Defense in Microgravity   
 

•NiH/Children's Hospital of Philadelphia- Lung Host Defense in Microgravity/Phase-II
 

•National Lab- The effects of microgravity on differentiation and cell growth in stem cells and cancer stem cells


•National Lab- The effect of microgravity on plasma-osteocalcin

 

•National Lab- The effect of medication changes in microgravity

•ISS National Lab/UAATapping Microgravity to Enhance the Biofuel Production/Phase-II
 

•ISS National Lab/Aphios Pharmaceuticals- Use of precision manufactured targeted nanoparticles for orphan and chronic diseases like Alzheimer’s disease in a microgravity environment using green SuperFluids technology


•GSK- Novel protein aggregation/degradation studies in the unique ISS environment provide mechanistic insights relevant to biopharmaceutical development and degenerative diseases
 

•GSK- Novel protein aggregation/degradation studies in the unique ISS environment provide mechanistic insights relevant to biopharmaceutical development and degenerative diseases/Phase-II
 

•SpacePharma- Identify biological mechanisms that affect changes leading to the production of unique tissue, plant or cell based molecular compounds
 

•NiH/UCSF- Microgravity as model for immunological senescence and Its impact on tissue stem cells and regeneration

AirbusA.jpg
GSK.jpg
NIH.jpg
NSF.jpg
TAM.jpg
UCLA.jpg
SpacePharma.jpg
UCF.jpg
Aphios.jpg

OUR PARTNERS

NASA.jpg
AirbusPartner.jpg
Kayser.jpg
Nyrad.jpg
Craig Tech.jpg
SCM.jpg
IronRing.jpg
SpacePharmaPartner.jpg
Alpha.jpg
VyriPharm.jpg
Raven.jpg